Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Digestive System Neoplasms 3Digestive System Diseases 3Gastrointestinal Neoplasms 2Gastrointestinal Diseases 2Endocrine System Diseases 2Endocrine Gland Neoplasms 2Urogenital Neoplasms 1Stomach Neoplasms 1Stomach Diseases 1Rectal Diseases 1Pancreatic Neoplasms 1Pancreatic Diseases 1Ovarian Neoplasms 1Ovarian Diseases 1Neoplasms, Glandular and Epithelial 1Neoplasm Metastasis 1Intestinal Neoplasms 1Intestinal Diseases 1Head and Neck Neoplasms 1Gonadal Disorders 1Genital Neoplasms, Female 1Genital Diseases, Female 1Female Urogenital Diseases and Pregnancy Complications 1Female Urogenital Diseases 1Esophageal Neoplasms 1Esophageal Diseases 1Colorectal Neoplasms 1Colonic Diseases 1Carcinoma 1Breast Neoplasms 1

Interventions

alvimopan 5Surveys and Questionnaires 2Cyclophosphamide 2pralsetinib 1pembrolizumab 1napabucasin 1guadecitabine 1Ursodeoxycholic Acid 1Surgical Procedures, Operative 1Pemetrexed 1Oxaliplatin 1Oviposition 1Ocoxin 1Low Density Lipoprotein Receptor-Related Protein-1 1Leucovorin 1Irinotecan 1Fluorouracil 1Exercise 1Drainage 1Colonoscopy 1Cetuximab 1Celecoxib 1Capecitabine 1Calcium Dobesilate 1Bupivacaine 1Bevacizumab 15-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide 15,10-methylenetetrahydrofolic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Intestinal Diseases × Ocoxin × Clear all
NCT03559543 2024-02-07

Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma

Catalysis SL

Phase 2 Completed
40 enrolled
Gastrointestinal

Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Rectal Diseases, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡